Evaxion Biotech AS (EVAX)

1.42 +0.05 (+3.65%) USD  |  NASDAQ  |  Nov 22, 16:00
1.42 0.00 (0.00%) After-Hours: 20:00
More

Evaxion Biotech EV to Assets (Quarterly)

EV to Assets (Quarterly) Chart

View EV to Assets (Quarterly) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Assets (Quarterly) Data

View and export this data back to 2023. Upgrade now.
Date Value
September 30, 2024 --
June 30, 2024 --
Date Value
March 31, 2024 --
December 31, 2023 --

Enterprise Value Ratios (EV) Definition

Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Read full definition.

EV to Assets (Quarterly) Range, Past 5 Years

Upgrade
Minimum
Mar 2024
Upgrade
Maximum
Dec 2023
Upgrade
Average
Upgrade
Median

EV to Assets (Quarterly) Benchmarks

Ascendis Pharma AS Upgrade
DBV Technologies SA --
Adaptimmune Therapeutics PLC Upgrade
Akari Therapeutics PLC --
Biodexa Pharmaceuticals PLC Upgrade

EV to Assets (Quarterly) Related Metrics

EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Earnings Upgrade